This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
O'Dwyer, Michael
| Item Type | Name |
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Lymphoid
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
|
Academic Article
|
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL.
|
|
Academic Article
|
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies.
|
|
Academic Article
|
Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia.
|
|
Academic Article
|
Clinical application of the I.B.M. cell separator.
|
|
Academic Article
|
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
|
|
Academic Article
|
The role of inflammation in leukaemia.
|
|
Academic Article
|
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias.
|
|
Academic Article
|
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.
|
|
Academic Article
|
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes.
|
|
Academic Article
|
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment.
|
|
Academic Article
|
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study.
|
|
Academic Article
|
Clofarabine in the treatment of poor risk acute myeloid leukaemia.
|
|
Academic Article
|
MYC dysregulation in the progression of multiple myeloma.
|
|
Academic Article
|
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
|
|
Academic Article
|
Drugging the unfolded protein response in acute leukemias.
|